William Chu

5.3k citations

161 papers · 2.9k indexed · h-index 29

Impact in

Radiation top 1%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment

Papers in ⓘ

Radiation 62
- Advanced Radiotherapy Techniques 61
Pulmonary and Respiratory Medicine 85
- Prostate Cancer Treatment and Research 52
- Prostate Cancer Diagnosis and Treatment 52
- Renal cell carcinoma treatment 15

Co-authors: Steven A. Narod (10 shared papers)Patrick Cheung (63 shared papers)Hans T. Chung (70 shared papers)Danny Vesprini (43 shared papers)Andrew Loblaw (40 shared papers)Anand Swaminath (16 shared papers)Helena Jernström (3 shared papers)M. P. McCormick (8 shared papers)
Journals: International Journal of Radiation Oncology*Biology*Physics (31 papers)Radiotherapy and Oncology (24 papers)Journal of Clinical Oncology (12 papers)Clinical Oncology (5 papers)The Journal of Urology (4 papers)
Partner nations: Canada United States Australia

In The Last Decade

William Chu

152 papers receiving 2.8k citations

Peers

Countries citing papers authored by William Chu

Since Specialization

Citations

This map shows the geographic impact of William Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Chu more than expected).

Fields of papers citing papers by William Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Chu. The network helps show where William Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside William Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Chu Line = papers co-authored together William Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer The American Journal of Human Genetics ·Roxana Moslehi, William Chu, Beth Y. Karlan, David A. Fishman, Harvey A. Risch, Abbie L. Fields, David Smotkin, Yehuda Ben‐David, Jacalyn Rosenblatt, Donna Russo, Peter E. Schwartz, Nadine Tung, Ellen Warner, Barry P. Rosen, Jan M. Friedman, Jean‐Sébastien Brunet, Steven A. Narod	2000	224
2	Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. PubMed ·Helena Jernström, Cheri Deal, Françoise Wilkin, William Chu, Y Tao, Noreen Majeed, Thomas J. Hudson, Steven A. Narod, Michaël Pollak	2001	155
3	Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) Cancer ·Shankar Siva, Alexander V. Louie, Andrew Warner, Alexander Muacevic, Senthilkumar Gandhidasan, Lee Ponsky, Rodney J. Ellis, Irving Kaplan, Anand Mahadevan, William Chu, Anand Swaminath, Hiroshi Onishi, Bin S. Teh, Rohann Correa, Simon S. Lo, Michael Staehler	2017	105
4	Genetic Factors Related to Racial Variation in Plasma Levels of Insulin-Like Growth Factor-1: Implications for Premenopausal Breast Cancer Risk Molecular Genetics and Metabolism ·Helena Jernström, William Chu, Danny Vesprini, Yuzhen Tao, Noreen Majeed, Cheri Deal, Michaël Pollak, Steven A. Narod	2001	98
5	The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis European Urology Focus ·Rohann Correa, Alexander V. Louie, Nicholas G. Zaorsky, Eric J. Lehrer, Rodney J. Ellis, Lee Ponsky, Irving Kaplan, Anand Mahadevan, William Chu, Anand Swaminath, Raquibul Hannan, Hiroshi Onishi, Bin S. Teh, Alexander Muacevic, Simon S. Lo, Michael Staehler, Shankar Siva	2019	98
6	Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy Radiotherapy and Oncology ·Gerard Morton, Merrylee McGuffin, Hans T. Chung, Chia‐Lin Tseng, Joelle Helou, Ananth Ravi, Patrick Cheung, Ewa Szumacher, Stanley K. Liu, William Chu, Liying Zhang, Alexandre Mamedov, Andrew Loblaw	2020	93
7	Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome? Gynecologic Oncology ·Ran Goshen, William Chu, Laurie Elit, Tuya Pal, Jalil Hakimi, Ida Ackerman, Anthony Fyles, Margot Mitchell, Steven A. Narod	2000	88
8	Stratospheric ozone profile and total ozone trends derived from the SAGE I and SAGE II data Geophysical Research Letters ·M. P. McCormick, Robert E. Veiga, William Chu	1992	85
9	Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter Study European Urology ·Patrick Cheung, Samir Patel, Scott North, Arjun Sahgal, William Chu, Hany Soliman, Belal Ahmad, Eric Winquist, Tamim Niazi, François Patenaude, Gerald Lim, Daniel Yick Chin Heng, Arbind Dubey, Piotr Czaykowski, Rebecca Wong, Anand Swaminath, Scott C. Morgan, Rupi Mangat, Sareh Keshavarzi, Georg A. Bjarnason	2021	82
10	V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression Urology ·R. Nam, Ants Toi, Danny Vesprini, Minnie Ho, William Chu, S Harvie, Joan Sweet, John Trachtenberg, Michael A.S. Jewett, Steven A. Narod	2001	76
11	Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer. PubMed ·Robert K. Nam, William Zhang, John Trachtenberg, Michael A.S. Jewett, Marjan Emami, Danny Vesprini, William Chu, Minnie Ho, Joan Sweet, Andrew Evans, Ants Toi, Michaël Pollak, Steven A. Narod	2003	66
12	SIGNIFICANCE OF THE CAG REPEAT POLYMORPHISM OF THE ANDROGEN RECEPTOR GENE IN PROSTATE CANCER PROGRESSION The Journal of Urology ·Robert K. Nam, Youssef Elhaji, Murray Krahn, Jalil Hakimi, Minnie Ho, William Chu, Joan Sweet, John Trachtenberg, Michael A.S. Jewett, Steven A. Narod	2000	64
13	CYP Gene Polymorphisms and Early Menarche Molecular Genetics and Metabolism ·Joe Lai, Danny Vesprini, William Chu, Helena Jernström, Steven A. Narod	2001	63
14	Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK) International Journal of Radiation OncologyBiologyPhysics ·Shankar Siva, Rohann Correa, Andrew Warner, Michael Staehler, Rodney J. Ellis, Lee Ponsky, Irving Kaplan, Anand Mahadevan, William Chu, Senthilkumar Gandhidasan, Anand Swaminath, Hiroshi Onishi, Bin S. Teh, Simon S. Lo, Alexander Muacevic, Alexander V. Louie	2020	51
15	Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial Radiotherapy and Oncology ·Harvey Quon, Aldrich Ong, Patrick Cheung, William Chu, Hans T. Chung, Danny Vesprini, Amit Chowdhury, Dilip Panjwani, Geordi Pang, Renée Korol, Melanie Davidson, Ananth Ravi, Boyd McCurdy, Liying Zhang, Alexandre Mamedov, Andrea Deabreu, Andrew Loblaw	2018	49
16	Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases Radiotherapy and Oncology ·Darby Erler, Drew Brotherston, Arjun Sahgal, Patrick Cheung, Andrew Loblaw, William Chu, Hany Soliman, Hans T. Chung, Alex Kiss, Edward Chow, Ian Poon	2018	46
17	Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience European Journal of Surgical Oncology ·Moisés Cukier, Andrew J. Smith, Laurent Milot, William Chu, Hans T. Chung, Darlene Fenech, Sender Herschorn, Y.J. Ko, Corwyn Rowsell, Hany Soliman, Yee Ung, C. Shun Wong	2012	45
18	Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience Clinical Oncology ·Joe H. Chang, Patrick Cheung, Darby Erler, Marcus Sonier, Roman Korol, William Chu	2016	44
19	Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life International Journal of Radiation OncologyBiologyPhysics ·Hima Bindu Musunuru, Laura D’Alimonte, Melanie Davidson, Ling Ho, Patrick Cheung, Daniel Vesprini, Stanley K. Liu, William Chu, Hans T. Chung, Ananth Ravi, Andrea Deabreu, Liying Zhang, Kristina Commisso, Andrew Loblaw	2018	41
20	Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy? Lung Cancer ·Tomás Merino Lara, Joelle Helou, Ian Poon, Arjun Sahgal, Hans T. Chung, William Chu, Hany Soliman, Yee Ung, Sunil Verma, Parneet Cheema, Susanna Y. Cheng, Suneil Khanna, Darby Erler, Liying Zhang, Patrick Cheung	2018	36

About William Chu

William Chu is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology and Atmospheric Science, having authored 161 papers that have together received 2.9k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (61 papers), Prostate Cancer Treatment and Research (52 papers), Prostate Cancer Diagnosis and Treatment (52 papers), Management of metastatic bone disease (16 papers), Renal cell carcinoma treatment (15 papers), Atmospheric Ozone and Climate (15 papers), Medical Imaging Techniques and Applications (11 papers) and Atmospheric and Environmental Gas Dynamics (10 papers). The work is most often cited by research in Radiation (654 citations), Pulmonary and Respiratory Medicine (1.3k citations), Reproductive Medicine (228 citations), Cancer Research (312 citations) and Oncology (558 citations). William Chu has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Steven A. Narod, Patrick Cheung, Hans T. Chung, Danny Vesprini, Andrew Loblaw, Anand Swaminath, Helena Jernström, M. P. McCormick, Liying Zhang and Robert E. Veiga. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Radiotherapy and Oncology, Journal of Clinical Oncology, Clinical Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact